Vimentin can regulate lymphocyte inflammatory responses and apoptosis in a cancer microenvironment by interacting with other inflammatory proteins, including heat shock protein 90 (HSP90), transmembrane protein 4 (TMP4) and 14-3-3 protein epsilon (YWHAE). Here, VIM is linked to cancer.